There is a growing body of evidence that already-approved IL-6 could be used as treatments for COVID-19 following newly published clinical trial data – but the jury is out on whether they could be licensed in the new use until larger trial results are published in the coming weeks.PharmaForum
Tuesday, April 28, 2020
Jury still out on IL-6 drugs in COVID-19 following preliminary trial results
There is a growing body of evidence that already-approved IL-6 could be used as treatments for COVID-19 following newly published clinical trial data – but the jury is out on whether they could be licensed in the new use until larger trial results are published in the coming weeks.PharmaForum
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment